SEC 13D/G

LABT - Lakewood-Amedex Biotherapeutics, Inc. - SEC Filing Update (06-AUG-2026) | ThinkSabio - Stocks Simplified

$LABT$2.35▼ -72.83% YTDOthersAug 6, 2026 · ThinkSabio Blog

SEC Filing Update: #LABT Lakewood-Amedex Biotherapeutics, Inc. : $2.35

Sector: Others | YTD: 🔽 -72.83% The SEC disclosed Today (06-AUG-2026) that LINDESFARNE LLC has Newly bought 203,360 #LABT shares Ownership: 9.88% * Estimated Investment Value: $447.39K https://www.thinksabio.com/reports/isr/LABT

Share this post

More filings for $LABT

LABT ▼ -5.3% - Lakewood-Amedex Biotherapeutics, Inc.Oct 1, 2026 LABT ▲ +99.4% - Lakewood-Amedex Biotherapeutics, Inc.Sep 28, 2026 LABT ▲ +88.0% - Lakewood-Amedex Biotherapeutics, Inc.Sep 28, 2026 LABT ▲ +10.6% - Lakewood-Amedex Biotherapeutics, Inc.Sep 24, 2026 LABT ▲ +12.6% - Lakewood-Amedex Biotherapeutics, Inc.Sep 21, 2026 LABT ▲ +1.1% - Lakewood-Amedex Biotherapeutics, Inc.Sep 8, 2026

View full $LABT filing history →

💬 Comments

Loading comments…